価格表

在庫・価格 : 2024年05月18日 05時45分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-LSD1, Mouse-Mono(1B2E5)
データシート※最新のデータシートでない場合があります
NB100-1762SS NOVノバス バイオロジカルス
Novus biologicals, LLC
0.025 ml ¥36,000
(未発注)
追加

在庫・価格 : 2024年05月18日 05時45分 現在

Anti-LSD1, Mouse-Mono(1B2E5)

  • 商品コード:NB100-1762SS
  • メーカー:NOV
  • 包装:0.025ml
  • 価格: ¥36,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Schildhaus HU et al. Lysine-specific demethylase 1 is highly expressed in solitary fibrous tumors, synovial sarcomas, rhabdomyosarcomas, desmoplastic small round cell tumors, and malignant peripheral nerve sheath tumors. Hum. Pathol. 2011 Nov;42(11):1667-
Schildhaus HU et al
2011/01/01
Species: Human, Applications: IHC, WB PubMed
2 Janzer A et al. Lysine-specific demethylase 1 (LSD1) and histone deacetylase 1 (HDAC1) synergistically repress proinflammatory cytokines and classical complement pathway components. Biochem. Biophys. Res. Commun. 2012 May;421(4):665-70
Janzer A et al
2012/01/01
Species: Human, Applications: ChIP, WB PubMed
3 Kauffman EC et al. Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer. Mol. Carcinog. 2011 Dec;50(12):931-44
Kauffman EC et al
2011/01/01
Species: Human, Applications: IHC PubMed
4 Bennani-Baiti IM et al. Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing"s sarcoma, osteosarcoma, and rhabdomyosarcoma. Hum. Pathol. 2012 Aug;43(8):1300-7
Bennani-Baiti IM et al
2012/01/01
Species: Human, Applications: IHC PubMed
5 Serce N et al. Elevated expression of LSD1 (Lysine-specific demethylase 1) during tumour progression from pre-invasive to invasive ductal carcinoma of the breast. BMC Clin Pathol 2012 Aug;12(1):13
Serce N et al
2012/01/01
Species: Human, Applications: IHC PubMed
6 Lim S et al. Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis 2010 Mar;31(3):512-20
Lim S et al
2010/01/01
Species: Human, Applications: IHC, ELISA, WB, ChIP PubMed
7 Pajtler KW et al. The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastoma. Acta Neuropathol Commun 2013;1(1):19
Pajtler KW et al
2013/01/01
Species: Mouse, Human, Applications: WB, IHC-P PubMed
8 Kashyap V et al. The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer. Mol Oncol 2013 Jan;
Kashyap V et al
2013/01/01
Species: Human, Applications: IHC, WB PubMed
  • No.: 1
  • 文献情報:
    Schildhaus HU et al. Lysine-specific demethylase 1 is highly expressed in solitary fibrous tumors, synovial sarcomas, rhabdomyosarcomas, desmoplastic small round cell tumors, and malignant peripheral nerve sheath tumors. Hum. Pathol. 2011 Nov;42(11):1667-
    Schildhaus HU et al
    2011/01/01
  • 備考:
    Species: Human, Applications: IHC, WB
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Janzer A et al. Lysine-specific demethylase 1 (LSD1) and histone deacetylase 1 (HDAC1) synergistically repress proinflammatory cytokines and classical complement pathway components. Biochem. Biophys. Res. Commun. 2012 May;421(4):665-70
    Janzer A et al
    2012/01/01
  • 備考:
    Species: Human, Applications: ChIP, WB
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Kauffman EC et al. Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer. Mol. Carcinog. 2011 Dec;50(12):931-44
    Kauffman EC et al
    2011/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Bennani-Baiti IM et al. Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing"s sarcoma, osteosarcoma, and rhabdomyosarcoma. Hum. Pathol. 2012 Aug;43(8):1300-7
    Bennani-Baiti IM et al
    2012/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Serce N et al. Elevated expression of LSD1 (Lysine-specific demethylase 1) during tumour progression from pre-invasive to invasive ductal carcinoma of the breast. BMC Clin Pathol 2012 Aug;12(1):13
    Serce N et al
    2012/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Lim S et al. Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis 2010 Mar;31(3):512-20
    Lim S et al
    2010/01/01
  • 備考:
    Species: Human, Applications: IHC, ELISA, WB, ChIP
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Pajtler KW et al. The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastoma. Acta Neuropathol Commun 2013;1(1):19
    Pajtler KW et al
    2013/01/01
  • 備考:
    Species: Mouse, Human, Applications: WB, IHC-P
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Kashyap V et al. The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer. Mol Oncol 2013 Jan;
    Kashyap V et al
    2013/01/01
  • 備考:
    Species: Human, Applications: IHC, WB
  • 参照:
    PubMed